Skip to content

Prevention network Western Pomerania: Mental and neurobiological health in pregnant women and young mothers

Prevention network Western Pomerania: Mental and neurobiological health in pregnant women and young mothers - PriVileG-M

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00017065
Enrollment
240
Registered
2019-05-02
Start date
2019-05-19
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prenatal und postnatal maternal mental and physical health prenatal und postnatal mental and physical health of the offspring

Interventions

Group 1: 1. control group: mentally stable women Group 2: 2. control group: mentally stressed women without intervention Group 3: Mentally stressed women with psychotherapeutic intervention and follow
telemedical intervention from week 26 postpartal until 52 weeks postpartal)

Sponsors

Universitätsmedizin Greifswald, Klinik und Poliklinik für Psychiatrie und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
17 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pregnant women are included if they are between 18 and 45 years of age and at the end of the second pregnancy trimester (25th to 29th week of pregnancy).

Exclusion criteria

Exclusion criteria: Women with multiple pregnancies or foreseeable developmental disabilities of the fetus, as well as women requiring withdrawal, exhibiting low motivation for therapy, suffering alcohol or drug addiction (DIPS), having severe psychosis or reporting suicidality (DIPS) need to be excluded. In addition, women being submitted to a recent psychiatric or psychotherapeutic treatment (or another study including such treatments) have to be excluded in order to impede confounding of therapeutic effects. Women who are 17 years old at the screenings, can be included, but will be excluded if they won't reach the age of 18 at delivery.

Design outcomes

Primary

MeasureTime frame
Concerning the women, interventions are expected to reduce mental stress (assessed by the BSI-18 to screening, baseline and 8-week, 26-week and 52-week follow-ups)

Secondary

MeasureTime frame
(1) concerning the women i. to improve quality of life ii. to enhance resilience iii. to increase rates of breastfeeding mothers (2) Concerning the children, interventions are expected i. to reduce rates of preterm birth as well as complications during childbirth ii. to reduce regulation disorders iii. to reduce developmental retardations iv. to strengthen physical health (3) Concerning women and children, interventions are expected i. to improve mother-child-interaction and to strengthen bonding (MAAS, PBQ, CARE Index) ii. to lower cortisol levels and to increase oxytocin levels in both mother and child The outcomes (1) to (3) are expected to converge to those of healthy mothers and children in the control group. In contrast, it is assumed that these outcomes depart in the group of stressed women without intervention from those of the intervention group. (4) In addition, the results of the study will lead to the development of a qualification measure for health professionals who will be trained to detect mental stress, and in turn to refer those women to professional institutions. The study aims to examine by explorative analysis hormonal transmissions between mother and child. Therefore, a biobank will be built up to analyse DNS-sequences, RNA-expression, miRNA as well as DNA methylation and other metabolomics. In particular, the study scrutinizes how the development of the HPA-axis in infants is shaped by depressive symptoms of the mother and how the HPA-axis in mother and infants is influenced by the different interventions of the study. Moreover, the constituents of breast milk will be analyzed, as well as hormonal responses of mother and child to stress. Quantitative and qualitative analysis of the subjective satisfaction of the woman as well as of the efficacy and feasability of the intervention study.

Countries

Germany

Contacts

Public ContactJuliane Corleis

Universitätsmedizin Greifswald, Klinik und Poliklinik für Psychiatrie und Psychotherapie

privileg@uni-greifswald.de01522 2406323

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 1, 2026